Form 4: Inovio Pharmaceuticals Director Ann Calby Miller Reports Stock Transactions

Director Ann Calby Miller reports the vesting and disposal of restricted stock units resulting in a change in beneficial ownership of Inovio Pharmaceuticals stock.

Summary

• On May 21, 2025, Ann Calby Miller, a director of Inovio Pharmaceuticals, reported transactions involving the company's stock.
• Miller disposed of 2,167 shares of common stock.
• These shares were obtained through the vesting of restricted stock units.
• Following the reported transactions, Miller beneficially owns 9,877 shares of Inovio Pharmaceuticals stock directly.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company leadership.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It helps stakeholders understand the ownership structure and potential alignment of interests between management and shareholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, INO, Inovio Pharmaceuticals, Director, Stock Transaction, Restricted Stock Units, Vesting